Evidence mapPaperPMID 41224734Full record

GuidelineJournal of feline medicine and surgery2025

iCatCare 2025 consensus guidelines on the diagnosis and management of diabetes mellitus in cats.

Samantha Taylor, Martha Cannon, David Church, Linda Fleeman, Federico Fracassi, Chen Gilor, Jocelyn Mott, Stijn Niessen

Abstract readReviewPractice Guideline
In one paragraph

Guideline in Journal of feline medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Rational approach to feline medical emergencies: part 2.Journal of feline medicine and surgery
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Samantha TaylorInternational Cat Care, Tisbury, Wiltshire, UK.ORCID 0000-0002-8668-0777
Martha CannonOxford Cat Clinic, Oxford, UK.ORCID 0000-0001-7006-6150
David ChurchRoyal Veterinary College, Potters Bar, Hertfordshire, UK.
Linda FleemanAnimal Diabetes Australia, Melbourne, VIC, Australia.ORCID 0000-0001-5732-7889
Federico FracassiDepartment of Veterinary Medical Sciences, University of Bologna, Italy.ORCID 0000-0003-3121-2199
Chen GilorUniversity of Florida, Gainesville, FL, USA.ORCID 0000-0003-0393-4135
Jocelyn MottUniversity of Florida, Gainesville, FL, USA.ORCID 0000-0002-2176-9287
Stijn NiessenRoyal Veterinary College, Potters Bar, Hertfordshire, UK; and Veterinary Specialist Consultations and VIN Europe, Hilversum, The Netherlands.ORCID 0009-0000-9667-6678

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

practical relevanceDiabetes mellitus (DM) is a common feline endocrine disease. Developments in therapy mean there are now more options for treatment, including various types of insulin and novel oral medications. Use of continuous glucose monitoring (CGM) devices has increased, providing more detailed information on affected cats. Selecting the appropriate treatment for DM, monitoring the cat's response and treating complications can present challenges, but these patients are nonetheless rewarding cases to manage for clinicians.

aimThe '2025 iCatCare consensus guidelines on the diagnosis and management of diabetes mellitus in cats' provide practical information on the management of complex as well as more routine cases. The importance of a team approach, involving veterinary professionals and the caregiver, is emphasised as this is likely to optimise patient outcomesClinical challenges:The pathogenesis of DM in cats, including absolute or relative insulin deficiency, can complicate management. Moreover, conditions such as hypersomatotropism, which is a prevalent underlying cause, as well as comorbidities that are common in affected populations of cats, warrant special consideration. Selecting the most appropriate therapy for the individual cat with DM relies on a thorough assessment of the case, including testing for comorbidities, if indicated, and excellent communication with caregivers. Treatment with either insulin or sodium-glucose cotransporter-2 inhibitors may be appropriate and should be combined with a diet and a monitoring regimen that are suitable and manageable for both cat and caregiver. Monitoring, to determine the response to treatment and to detect complications such as diabetic ketoacidosis or hypoglycaemia, may include placement of a CGM device. EVIDENCE BASE: These Guidelines have been created by a panel of experts brought together by the International Cat Care (iCatCare) Veterinary Society. Information is based on the available literature, expert opinion and the panel members' experience.

Indexed as

Cat DiseasesDiabetes MellitusAnimalsCatsConsensusHypoglycemic AgentsInsulinVeterinary MedicineHypoglycemic AgentsInsulincontinuous glucose monitoringglucoseHypersomatotropisminsulinSGLT2isodium–glucose cotransporter-2 inhibitor

Identifiers

PMID41224734
PMCPMC12612538

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.